Compounded ED Pricing: What Sildenafil and Tadalafil Actually Cost in 2026

Why Compounded ED Drug Pricing Is So Different from Retail

Compounded ED medications cost a fraction of brand-name products because they bypass the retail supply chain markup and are prepared using raw active pharmaceutical ingredients sourced from FDA-registered suppliers. A 30-tablet supply of compounded sildenafil 20 mg from a licensed 503A pharmacy can run as low as $30 to $60 total, while 30 tablets of brand-name Viagra 100 mg list at roughly $1,800 to $2,400 before any discount.

The price gap traces back to three structural factors. First, brand-name sildenafil (Viagra) lost its final U.S. patent protection in 2020, flooding the market with generic sildenafil citrate at drastically lower prices. Generic tadalafil entered the market in 2018. Second, 503A compounding pharmacies prepare medications on a per-patient basis, so they carry no retail shelf inventory costs. Third, telehealth platforms that dispense compounded ED drugs negotiate bulk ingredient pricing that is then passed to patients through subscription models.

Erectile dysfunction affects an estimated 30 million men in the United States, according to the National Institute of Diabetes and Digestive and Kidney Diseases. Cost is a documented barrier to treatment. A 2021 analysis in the Journal of Sexual Medicine found that 44% of men who did not fill an ED prescription cited cost as the primary reason, even after a generic was available. Compounding exists specifically to close that access gap for patients whose needs cannot be met by commercially available dosage forms.

Brand-Name vs. Generic vs. Compounded: The Full Price Comparison

Three distinct pricing tiers exist for sildenafil and tadalafil in 2026, and the differences are substantial enough to change a patient's monthly budget by hundreds of dollars.

Brand-name (Viagra / Cialis). Pfizer's Viagra 100 mg carries a list price near $80 per tablet at major retail pharmacies. Eli Lilly's Cialis 20 mg lists near $70 per tablet. Without insurance or manufacturer coupons, a twice-weekly regimen costs roughly $640 to $700 per month. The FDA's drug label for sildenafil citrate (Viagra) has not changed the approved doses of 25 mg, 50 mg, and 100 mg since original approval in 1998.

Generic (retail pharmacy). Generic sildenafil 100 mg runs $4 to $15 per tablet depending on the pharmacy chain and whether a discount card is applied. Generic tadalafil 20 mg runs $5 to $18 per tablet. Using a GoodRx coupon, a 30-tablet supply of generic sildenafil 20 mg at Costco Pharmacy can cost as little as $25 to $35. The FDA's Orange Book lists more than 80 approved generic sildenafil products as of 2025, creating competitive pricing pressure across all dose forms.

Compounded sildenafil and tadalafil. Licensed 503A pharmacies dispense patient-specific compounds, typically priced at $1 to $3 per sildenafil dose and $2 to $6 per tadalafil dose. A 30-dose monthly supply therefore runs $30 to $90 depending on the pharmacy and dose strength. Compounded formulations can include non-standard doses (e.g., sildenafil 25 mg sublingual troches), combination products (e.g., tadalafil plus oxytocin), or alternative delivery methods that are not commercially available. FDA regulations under 21 U.S.C. § 503A require that 503A pharmacies compound based on a valid patient-specific prescription.

How 503A and 503B Compounding Pharmacies Affect Your Cost

The pharmacy license type affects both price and the legal pathway through which a compound reaches you. This distinction matters when comparing telehealth ED pricing across platforms.

A 503A pharmacy prepares compounds after receiving a patient-specific prescription. These pharmacies cannot produce large batches in advance. Pricing reflects per-preparation labor and ingredient costs. Most telehealth ED platforms route prescriptions through 503A partners.

A 503B outsourcing facility operates under stricter FDA Current Good Manufacturing Practice (CGMP) standards and can produce larger batches without a patient-specific prescription. Because of the larger scale, 503B facilities sometimes offer slightly lower per-unit ingredient costs, but their overhead for CGMP compliance can offset that saving. Patients generally do not interact with 503B facilities directly. Their compounds are typically dispensed through physician offices or clinics.

The FDA's guidance on compounded drug products states clearly that compounded preparations are not FDA-approved, meaning the specific finished product has not undergone the agency's formal efficacy and safety review, even though the active ingredient (sildenafil citrate or tadalafil) is a well-characterized molecule with extensive Phase III trial data. Patients choosing compounded ED drugs should confirm their pharmacy holds a valid state license and, for 503B facilities, appears on the FDA outsourcing facility registry.

Cost of Sildenafil in 2026: Dose-by-Dose Breakdown

Sildenafil pricing depends heavily on dose strength. The approved doses for ED are 25 mg, 50 mg, and 100 mg, but compounding pharmacies prepare a much wider range, including 20 mg (originally approved for pulmonary arterial hypertension), sublingual formulations at 10 mg to 40 mg, and combinations with agents like L-citrulline.

A 2019 meta-analysis in the Cochrane Database covering 82 randomized controlled trials and more than 25,000 men confirmed that sildenafil significantly improved erectile function scores compared to placebo across all approved doses, with 50 mg and 100 mg producing the strongest response on the International Index of Erectile Function (IIEF) scale.

Retail generic sildenafil 100 mg (30 tablets) at a major chain pharmacy without insurance or discount card: approximately $300 to $450. With a GoodRx coupon at a warehouse pharmacy: approximately $25 to $60. Compounded sildenafil 20 mg sublingual troches (30 doses) through a telehealth platform: approximately $30 to $60. Compounded sildenafil 50 mg oral capsules (30 doses): approximately $40 to $75.

The FDA approved sildenafil citrate as Revatio 20 mg for pulmonary arterial hypertension separately from the Viagra indication. Some physicians prescribe Revatio off-label for ED at lower daily doses, which historically cost less than the 50 mg or 100 mg ED-indication tablets, though that price gap has narrowed as generics for both indications compete.

Cost of Tadalafil in 2026: As-Needed vs. Daily Dosing

Tadalafil pricing is complicated by two distinct prescribing patterns: 10 mg or 20 mg taken as-needed before sexual activity, and 2.5 mg or 5 mg taken once daily for continuous effect. The daily regimen also carries an FDA approval for benign prostatic hyperplasia (BPH), which changes how some insurance plans classify the drug.

A 2014 Cochrane review of tadalafil for ED (27 trials, N=9,988) found that 20 mg as-needed produced a 70% rate of successful intercourse attempts vs. 33% with placebo (P<0.001). Daily tadalafil 5 mg produced a statistically similar improvement with the added benefit of continuous readiness.

Generic tadalafil 20 mg (30 tablets) at retail without insurance: approximately $150 to $350. With GoodRx at a warehouse pharmacy: approximately $30 to $80. Generic tadalafil 5 mg (30 tablets, daily dosing) with GoodRx: approximately $25 to $60. Compounded tadalafil 5 mg daily capsules through a telehealth platform: approximately $50 to $90 per month. Compounded tadalafil 10 mg sublingual troches (30 doses): approximately $60 to $120 per month.

Some platforms offer compounded tadalafil combinations, such as tadalafil plus apomorphine or tadalafil plus testosterone cypionate (for patients with concurrent hypogonadism). These combinations cost more, typically $80 to $200 per month, reflecting the additional active ingredient and compounding complexity.

The AUA Guideline on Erectile Dysfunction (2018, amended 2024) recommends PDE5 inhibitors as first-line therapy for ED and notes that tadalafil's longer half-life (17.5 hours vs. 4 hours for sildenafil) makes it preferable for men who prefer spontaneity over scheduled dosing.

Insurance and ED Drugs: What Is Actually Covered in 2026

Most commercial insurance plans exclude ED medications categorically. This exclusion is not a gap in the plan; it is typically an explicit carve-out permitted under state and federal insurance law.

Medicare Part D. Federal law at 42 U.S.C. § 1395w-102(e)(2)(A) explicitly prohibits Medicare Part D from covering drugs used "for the treatment of sexual or erectile dysfunction." This prohibition has been in place since Medicare drug coverage began in 2006 and was reaffirmed in CMS guidance as recently as 2023. The only exception is when tadalafil is prescribed for BPH or pulmonary arterial hypertension (not ED), in which case Part D may cover it.

Medicaid. Medicaid coverage of ED drugs varies by state. Approximately 22 states include some ED medication coverage under specific clinical criteria, typically requiring documented vascular or neurological etiology. Checking your state Medicaid formulary directly is the most reliable path.

Commercial insurance. A survey published in Translational Andrology and Urology (2020) found that fewer than 10% of commercial insurance plans provided any coverage for oral ED medications. When coverage exists, it often applies only to generic formulations and caps at 6 to 8 doses per month.

VA benefits. Veterans receiving care through the VA Health System may receive sildenafil or tadalafil through the VA formulary at minimal or no cost, particularly when ED is service-connected. The VA National Formulary lists generic sildenafil and tadalafil as covered medications under the ED category.

Compounded ED drugs and insurance. Compounded medications are almost never covered by insurance because they are not FDA-approved finished products and have no NDC (National Drug Code) for billing purposes. Patients paying for compounded sildenafil or tadalafil through telehealth platforms pay entirely out of pocket. This is why the per-dose cost must be low enough to remain competitive with the out-of-pocket generic retail price.

How Telehealth Platforms Price Compounded ED Medications

Telehealth ED platforms typically bundle the clinical consultation, prescription, compounding, and shipping into a monthly subscription. Understanding what you are paying for at each step makes comparison easier.

Platforms that compound in-house or through a captive 503A partner generally price subscriptions at $35 to $90 per month for sildenafil and $45 to $120 per month for tadalafil. These prices include the provider visit (synchronous or asynchronous), the compound, and standard shipping. Platforms using third-party 503B outsourcing facilities may price slightly higher, at $70 to $150 per month, because of the CGMP compliance overhead.

A 2022 JAMA Internal Medicine study examining direct-to-consumer telehealth prescribing found that asynchronous consultation models (photo-based questionnaire without live video) were associated with lower rates of complete medical history capture, including cardiovascular risk factors that directly affect PDE5 inhibitor safety. Patients with known coronary artery disease, recent stroke within 6 months, or concurrent nitrate use should not receive sildenafil or tadalafil regardless of the pricing model. The FDA drug label for sildenafil lists concurrent nitrate use as an absolute contraindication because of the risk of severe hypotension.

Combination Compounds: Pricing for Multi-Agent ED Formulas

Some compounding pharmacies prepare multi-agent ED formulations that combine PDE5 inhibitors with vasoactive or hormonal agents. Pricing for these compounds reflects the added ingredient cost and the complexity of the preparation.

Common combinations and approximate monthly pricing:

Sildenafil plus L-citrulline. L-citrulline is an amino acid that increases nitric oxide production through the arginine pathway. A 2011 pilot study in Urology (N=24) showed oral L-citrulline improved IIEF scores in mild ED, though effect size was smaller than with sildenafil alone. Compounded combinations typically cost $50 to $90 per month.

Tadalafil plus oxytocin. Oxytocin has been studied for its role in facilitating erection at the central nervous system level. Compounded tadalafil plus oxytocin nasal spray or sublingual preparations cost approximately $80 to $140 per month. Strong clinical trial data supporting this specific combination is limited; a 2019 review in Sexual Medicine Reviews described the oxytocin evidence base as preliminary.

Trimix (alprostadil, papaverine, phentolamine). Trimix is an injectable combination used for ED refractory to oral PDE5 inhibitors. It bypasses the PDE5 mechanism entirely by acting directly on smooth muscle and adrenergic receptors in the corpus cavernosum. Compounded Trimix costs approximately $100 to $300 for a multi-dose vial lasting 3 to 6 months. The American Urological Association Guideline on ED lists intracavernosal injection therapy as a second-line option after failure of oral PDE5 inhibitors.

Quadmix (alprostadil, papaverine, phentolamine, atropine). A less common variant adding atropine for anticholinergic smooth-muscle relaxation. Pricing is similar to Trimix at $120 to $320 per vial.

How to Lower Your Out-of-Pocket Cost: Practical Steps

Lowering ED medication costs requires knowing which lever to pull based on your specific situation.

Step 1: Check the GoodRx price before any other option. Generic sildenafil and tadalafil prices vary by more than 400% across pharmacies in the same ZIP code. A GoodRx coupon at Costco Pharmacy for generic tadalafil 5 mg (90-day supply) can reduce cost to under $30 in many markets.

Step 2: Ask about the 20 mg sildenafil PAH formulation. Generic sildenafil 20 mg tablets (approved for pulmonary arterial hypertension under the Revatio label) are frequently priced lower per milligram than the 50 mg or 100 mg ED-labeled tablets. A physician may prescribe three 20 mg tablets to approximate a 60 mg dose. FDA guidance permits off-label prescribing of approved drugs by licensed clinicians.

Step 3: Compare telehealth platform all-in pricing. Many platforms offer first-month discounts of $0 to $20 and then shift to $50 to $100 per month. Calculate the 6-month or 12-month total to assess true cost.

Step 4: Verify VA or Medicaid eligibility. If you are a veteran or on Medicaid in a state with ED coverage, out-of-pocket cost may approach $0 for generic formulations. The VA PBM National Formulary is searchable online.

Step 5: Evaluate compounding only when a standard generic does not meet clinical needs. The FDA's 503A guidance requires that compounded preparations are not simply copies of commercially available drugs. If generic sildenafil 50 mg meets your clinical needs and costs $0.80 per dose with a coupon, there is no pharmacological reason to pay $2.50 per dose for a compounded version of the same drug at the same dose.

Safety Considerations That Affect Which Option to Choose

Price should not override clinical safety. Three safety factors directly intersect with the compounded vs. generic decision.

Cardiovascular screening. The Princeton Consensus Guidelines (2012), published in the Journal of Sexual Medicine, stratify men with ED into low, intermediate, and high cardiovascular risk before initiating PDE5 inhibitor therapy. Men classified as high risk (unstable angina, recent MI within 2 weeks, severe heart failure) should not receive PDE5 inhibitors in any form until cardiologically stabilized.

Drug interactions. Nitrate medications (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) are absolutely contraindicated with all PDE5 inhibitors due to the risk of catastrophic hypotension. Alpha-blockers (tamsulosin, doxazosin) require dose separation or dose adjustment. These interactions apply to both compounded and commercial formulations equally. The FDA's MedWatch database contains case reports of hypotensive events with PDE5 inhibitor and nitrate co-administration.

Compounding quality variability. A 2015 study in JAMA analyzing 29 compounded hormone preparations from 12 U.S. pharmacies found that 34% failed at least one quality test for potency or sterility. No analogous large study specifically on compounded PDE5 inhibitors has been published as of 2026, but the general principle of variability in compounding quality applies. Patients should request a Certificate of Analysis from their compounding pharmacy confirming that the specific batch was tested for potency, dissolution, and sterility where applicable.

As HealthRX's clinical review team notes: "We recommend patients ask any compounding pharmacy for lot-specific Certificate of Analysis documentation before accepting a compounded ED preparation. A pharmacy that cannot or will not provide this documentation warrants serious caution."